APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Halogenated Hydrocarbon General Anesthetics

Compare research editions
View pricing & licenses

Selected research

Industry Research

Halogenated Hydrocarbon General Anesthetics Industry Research Report 2026

27 December 2025128 pages

Choose your research edition.

Industry ResearchHalogenated Hydrocarbon General Anesthetics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Halogenated Hydrocarbon General Anesthetics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Halogenated Hydrocarbon General Anesthetics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Halogenated Hydrocarbon General Anesthetics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Halogenated Hydrocarbon General Anesthetics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Halogenated Hydrocarbon General Anesthetics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Halogenated Hydrocarbon General Anesthetics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Halogenated Hydrocarbon General Anesthetics is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Halogenated Hydrocarbon General Anesthetics is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Halogenated Hydrocarbon General Anesthetics include AbbVie, Baxter, Halocarbon, Piramal Critical Care, Fujian Haixi United Pharmaceutical Co., Ltd., Hebei Sams Pharmaceutical Co., Ltd., Hebei Yipin Pharmaceutical Co., Ltd., Lunan Beite Pharmaceutical Co., Ltd. and Shandong New Era Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Halogenated Hydrocarbon General Anesthetics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Halogenated Hydrocarbon General Anesthetics Market by Company

AbbVie

Baxter

Halocarbon

Piramal Critical Care

Fujian Haixi United Pharmaceutical Co., Ltd.

Hebei Sams Pharmaceutical Co., Ltd.

Hebei Yipin Pharmaceutical Co., Ltd.

Lunan Beite Pharmaceutical Co., Ltd.

Shandong New Era Pharmaceutical Co., Ltd.

Shanghai Hengrui Medicine Co., Ltd.

Sichuan Baili Pharmaceutical Co., Ltd.

Halogenated Hydrocarbon General Anesthetics Segment by Type

Sevoflurane

Enflurane

Desflurane

Halogenated Hydrocarbon General Anesthetics Segment by Application

Hospital

Clinic

Other

Halogenated Hydrocarbon General Anesthetics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Halogenated Hydrocarbon General Anesthetics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Halogenated Hydrocarbon General Anesthetics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Halogenated Hydrocarbon General Anesthetics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Halogenated Hydrocarbon General Anesthetics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Halogenated Hydrocarbon General Anesthetics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Halogenated Hydrocarbon General Anesthetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Halogenated Hydrocarbon General Anesthetics Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Halogenated Hydrocarbon General Anesthetics Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Manufacturers (2021-2026) Table 8. Global Halogenated Hydrocarbon General Anesthetics Revenue of Manufacturers (2021-2026) Table 9. Global Halogenated Hydrocarbon General Anesthetics Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Halogenated Hydrocarbon General Anesthetics Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Halogenated Hydrocarbon General Anesthetics Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Halogenated Hydrocarbon General Anesthetics, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Halogenated Hydrocarbon General Anesthetics, Product Type & Application Table 14. Global Halogenated Hydrocarbon General Anesthetics Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Halogenated Hydrocarbon General Anesthetics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. AbbVie Company Information Table 19. AbbVie Business Overview Table 20. AbbVie Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. AbbVie Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 22. AbbVie Recent Developments Table 23. Baxter Company Information Table 24. Baxter Business Overview Table 25. Baxter Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Baxter Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 27. Baxter Recent Developments Table 28. Halocarbon Company Information Table 29. Halocarbon Business Overview Table 30. Halocarbon Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Halocarbon Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 32. Halocarbon Recent Developments Table 33. Piramal Critical Care Company Information Table 34. Piramal Critical Care Business Overview Table 35. Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 37. Piramal Critical Care Recent Developments Table 38. Fujian Haixi United Pharmaceutical Co., Ltd. Company Information Table 39. Fujian Haixi United Pharmaceutical Co., Ltd. Business Overview Table 40. Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 42. Fujian Haixi United Pharmaceutical Co., Ltd. Recent Developments Table 43. Hebei Sams Pharmaceutical Co., Ltd. Company Information Table 44. Hebei Sams Pharmaceutical Co., Ltd. Business Overview Table 45. Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 47. Hebei Sams Pharmaceutical Co., Ltd. Recent Developments Table 48. Hebei Yipin Pharmaceutical Co., Ltd. Company Information Table 49. Hebei Yipin Pharmaceutical Co., Ltd. Business Overview Table 50. Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 52. Hebei Yipin Pharmaceutical Co., Ltd. Recent Developments Table 53. Lunan Beite Pharmaceutical Co., Ltd. Company Information Table 54. Lunan Beite Pharmaceutical Co., Ltd. Business Overview Table 55. Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 57. Lunan Beite Pharmaceutical Co., Ltd. Recent Developments Table 58. Shandong New Era Pharmaceutical Co., Ltd. Company Information Table 59. Shandong New Era Pharmaceutical Co., Ltd. Business Overview Table 60. Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 62. Shandong New Era Pharmaceutical Co., Ltd. Recent Developments Table 63. Shanghai Hengrui Medicine Co., Ltd. Company Information Table 64. Shanghai Hengrui Medicine Co., Ltd. Business Overview Table 65. Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 67. Shanghai Hengrui Medicine Co., Ltd. Recent Developments Table 68. Sichuan Baili Pharmaceutical Co., Ltd. Company Information Table 69. Sichuan Baili Pharmaceutical Co., Ltd. Business Overview Table 70. Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio Table 72. Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments Table 73. Global Halogenated Hydrocarbon General Anesthetics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Halogenated Hydrocarbon General Anesthetics Sales by Region (2021-2026) & (K Units) Table 75. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Region (2021-2026) Table 76. Global Halogenated Hydrocarbon General Anesthetics Sales by Region (2027-2032) & (K Units) Table 77. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Region (2027-2032) Table 78. Global Halogenated Hydrocarbon General Anesthetics Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Region (2021-2026) Table 80. Global Halogenated Hydrocarbon General Anesthetics Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Region (2027-2032) Table 82. North America Halogenated Hydrocarbon General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 84. North America Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 85. North America Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Halogenated Hydrocarbon General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Halogenated Hydrocarbon General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 89. Europe Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 90. Europe Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Halogenated Hydrocarbon General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Halogenated Hydrocarbon General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 94. Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 95. Asia Pacific Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Halogenated Hydrocarbon General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Halogenated Hydrocarbon General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 99. South America Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 100. South America Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Halogenated Hydrocarbon General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2026) & (K Units) Table 104. Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales by Country (2027-2032) & (K Units) Table 105. Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2021-2026) & (K Units) Table 108. Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2027-2032) & (K Units) Table 109. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2021-2026) Table 110. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2027-2032) Table 111. Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Type (2021-2026) Table 114. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Type (2027-2032) Table 115. Global Halogenated Hydrocarbon General Anesthetics Price by Type (2021-2026) & (US$/Unit) Table 116. Global Halogenated Hydrocarbon General Anesthetics Price by Type (2027-2032) & (US$/Unit) Table 117. Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2021-2026) & (K Units) Table 118. Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2027-2032) & (K Units) Table 119. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Application (2021-2026) Table 120. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Application (2027-2032) Table 121. Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Application (2021-2026) Table 124. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Application (2027-2032) Table 125. Global Halogenated Hydrocarbon General Anesthetics Price by Application (2021-2026) & (US$/Unit) Table 126. Global Halogenated Hydrocarbon General Anesthetics Price by Application (2027-2032) & (US$/Unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Halogenated Hydrocarbon General Anesthetics Distributors List Table 130. Halogenated Hydrocarbon General Anesthetics Customers List Table 131. Halogenated Hydrocarbon General Anesthetics Industry Trends Table 132. Halogenated Hydrocarbon General Anesthetics Industry Drivers Table 133. Halogenated Hydrocarbon General Anesthetics Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Halogenated Hydrocarbon General Anesthetics Product Image Figure 5. Global Halogenated Hydrocarbon General Anesthetics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Halogenated Hydrocarbon General Anesthetics Market Size (2021-2032) & (US$ Million) Figure 7. Global Halogenated Hydrocarbon General Anesthetics Sales (2021-2032) & (K Units) Figure 8. Global Halogenated Hydrocarbon General Anesthetics Average Price (US$/Unit) & (2021-2032) Figure 9. Sevoflurane Product Image Figure 10. Enflurane Product Image Figure 11. Desflurane Product Image Figure 12. Hospital Product Image Figure 13. Clinic Product Image Figure 14. Other Product Image Figure 15. Global Halogenated Hydrocarbon General Anesthetics Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Halogenated Hydrocarbon General Anesthetics, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Halogenated Hydrocarbon General Anesthetics Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Halogenated Hydrocarbon General Anesthetics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Halogenated Hydrocarbon General Anesthetics Sales by Region in 2025 Figure 21. Global Halogenated Hydrocarbon General Anesthetics Revenue by Region in 2025 Figure 22. North America Halogenated Hydrocarbon General Anesthetics Market Size by Country in 2025 Figure 23. North America Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 24. North America Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Country (2021-2032) Figure 25. United States Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Mexico Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Europe Halogenated Hydrocarbon General Anesthetics Market Size by Country in 2025 Figure 29. Europe Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 30. Europe Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Country (2021-2032) Figure 31. Germany Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. France Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. U.K. Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Italy Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Russia Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Spain Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Switzerland Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Sweden Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Poland Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Asia Pacific Halogenated Hydrocarbon General Anesthetics Market Size by Country in 2025 Figure 42. Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 43. Asia Pacific Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Country (2021-2032) Figure 44. China Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Japan Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South Korea Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. India Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Australia Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Taiwan Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. South America Halogenated Hydrocarbon General Anesthetics Market Size by Country in 2025 Figure 53. South America Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 54. South America Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Country (2021-2032) Figure 55. Brazil Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Argentina Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Chile Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Colombia Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Halogenated Hydrocarbon General Anesthetics Market Size by Country in 2025 Figure 60. Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Country (2021-2032) Figure 62. Egypt Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Halogenated Hydrocarbon General Anesthetics Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2021-2032) Figure 68. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Type (2021-2032) Figure 69. Global Halogenated Hydrocarbon General Anesthetics Price (US$/Unit) by Type (2021-2032) Figure 70. Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Application (2021-2032) Figure 71. Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Application (2021-2032) Figure 72. Global Halogenated Hydrocarbon General Anesthetics Price (US$/Unit) by Application (2021-2032) Figure 73. Halogenated Hydrocarbon General Anesthetics Value Chain Figure 74. Halogenated Hydrocarbon General Anesthetics Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Halogenated Hydrocarbon General Anesthetics Industry Opportunities and Challenges

Scope & coverage.

Types
  • Sevoflurane
  • Enflurane
  • Desflurane
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • AbbVie
  • Baxter
  • Halocarbon
  • Piramal Critical Care
  • Fujian Haixi United Pharmaceutical Co., Ltd.
  • Hebei Sams Pharmaceutical Co., Ltd.
  • Hebei Yipin Pharmaceutical Co., Ltd.
  • Lunan Beite Pharmaceutical Co., Ltd.
  • Shandong New Era Pharmaceutical Co., Ltd.
  • Shanghai Hengrui Medicine Co., Ltd.
  • Sichuan Baili Pharmaceutical Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Halogenated Hydrocarbon General Anesthetics Market Size (2021-2032)
  4. 2.2.2 Global Halogenated Hydrocarbon General Anesthetics Sales (2021-2032)
  5. 2.2.3 Global Halogenated Hydrocarbon General Anesthetics Market Average Price (2021-2032)
  6. 2.3 Halogenated Hydrocarbon General Anesthetics by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Sevoflurane
  9. 2.3.3 Enflurane
  10. 2.3.4 Desflurane
  11. 2.4 Halogenated Hydrocarbon General Anesthetics by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 Hospital
  14. 2.4.3 Clinic
  15. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Halogenated Hydrocarbon General Anesthetics Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Halogenated Hydrocarbon General Anesthetics Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Halogenated Hydrocarbon General Anesthetics Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Halogenated Hydrocarbon General Anesthetics Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Halogenated Hydrocarbon General Anesthetics Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Halogenated Hydrocarbon General Anesthetics, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Halogenated Hydrocarbon General Anesthetics, Product Type & Application
  8. 3.8 Global Manufacturers of Halogenated Hydrocarbon General Anesthetics, Established Date
  9. 3.9 Global Halogenated Hydrocarbon General Anesthetics Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 AbbVie
  2. 4.1.1 AbbVie Company Information
  3. 4.1.2 AbbVie Business Overview
  4. 4.1.3 AbbVie Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 AbbVie Halogenated Hydrocarbon General Anesthetics Product Portfolio
  6. 4.1.5 AbbVie Recent Developments
  7. 4.2 Baxter
  8. 4.2.1 Baxter Company Information
  9. 4.2.2 Baxter Business Overview
  10. 4.2.3 Baxter Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Baxter Halogenated Hydrocarbon General Anesthetics Product Portfolio
  12. 4.2.5 Baxter Recent Developments
  13. 4.3 Halocarbon
  14. 4.3.1 Halocarbon Company Information
  15. 4.3.2 Halocarbon Business Overview
  16. 4.3.3 Halocarbon Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Halocarbon Halogenated Hydrocarbon General Anesthetics Product Portfolio
  18. 4.3.5 Halocarbon Recent Developments
  19. 4.4 Piramal Critical Care
  20. 4.4.1 Piramal Critical Care Company Information
  21. 4.4.2 Piramal Critical Care Business Overview
  22. 4.4.3 Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Piramal Critical Care Halogenated Hydrocarbon General Anesthetics Product Portfolio
  24. 4.4.5 Piramal Critical Care Recent Developments
  25. 4.5 Fujian Haixi United Pharmaceutical Co., Ltd.
  26. 4.5.1 Fujian Haixi United Pharmaceutical Co., Ltd. Company Information
  27. 4.5.2 Fujian Haixi United Pharmaceutical Co., Ltd. Business Overview
  28. 4.5.3 Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Fujian Haixi United Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  30. 4.5.5 Fujian Haixi United Pharmaceutical Co., Ltd. Recent Developments
  31. 4.6 Hebei Sams Pharmaceutical Co., Ltd.
  32. 4.6.1 Hebei Sams Pharmaceutical Co., Ltd. Company Information
  33. 4.6.2 Hebei Sams Pharmaceutical Co., Ltd. Business Overview
  34. 4.6.3 Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Hebei Sams Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  36. 4.6.5 Hebei Sams Pharmaceutical Co., Ltd. Recent Developments
  37. 4.7 Hebei Yipin Pharmaceutical Co., Ltd.
  38. 4.7.1 Hebei Yipin Pharmaceutical Co., Ltd. Company Information
  39. 4.7.2 Hebei Yipin Pharmaceutical Co., Ltd. Business Overview
  40. 4.7.3 Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Hebei Yipin Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  42. 4.7.5 Hebei Yipin Pharmaceutical Co., Ltd. Recent Developments
  43. 4.8 Lunan Beite Pharmaceutical Co., Ltd.
  44. 4.8.1 Lunan Beite Pharmaceutical Co., Ltd. Company Information
  45. 4.8.2 Lunan Beite Pharmaceutical Co., Ltd. Business Overview
  46. 4.8.3 Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Lunan Beite Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  48. 4.8.5 Lunan Beite Pharmaceutical Co., Ltd. Recent Developments
  49. 4.9 Shandong New Era Pharmaceutical Co., Ltd.
  50. 4.9.1 Shandong New Era Pharmaceutical Co., Ltd. Company Information
  51. 4.9.2 Shandong New Era Pharmaceutical Co., Ltd. Business Overview
  52. 4.9.3 Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Shandong New Era Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  54. 4.9.5 Shandong New Era Pharmaceutical Co., Ltd. Recent Developments
  55. 4.10 Shanghai Hengrui Medicine Co., Ltd.
  56. 4.10.1 Shanghai Hengrui Medicine Co., Ltd. Company Information
  57. 4.10.2 Shanghai Hengrui Medicine Co., Ltd. Business Overview
  58. 4.10.3 Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Shanghai Hengrui Medicine Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  60. 4.10.5 Shanghai Hengrui Medicine Co., Ltd. Recent Developments
  61. 4.11 Sichuan Baili Pharmaceutical Co., Ltd.
  62. 4.11.1 Sichuan Baili Pharmaceutical Co., Ltd. Company Information
  63. 4.11.2 Sichuan Baili Pharmaceutical Co., Ltd. Business Overview
  64. 4.11.3 Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Sichuan Baili Pharmaceutical Co., Ltd. Halogenated Hydrocarbon General Anesthetics Product Portfolio
  66. 4.11.5 Sichuan Baili Pharmaceutical Co., Ltd. Recent Developments
5 Global Halogenated Hydrocarbon General Anesthetics Market Scenario by Region
  1. 5.1 Global Halogenated Hydrocarbon General Anesthetics Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Region: 2021-2032
  3. 5.2.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Region: 2021-2026
  4. 5.2.2 Global Halogenated Hydrocarbon General Anesthetics Sales by Region: 2027-2032
  5. 5.3 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region: 2021-2032
  6. 5.3.1 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region: 2021-2026
  7. 5.3.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Region: 2027-2032
  8. 5.4 North America Halogenated Hydrocarbon General Anesthetics Market Facts & Figures by Country
  9. 5.4.1 North America Halogenated Hydrocarbon General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  11. 5.4.3 North America Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Halogenated Hydrocarbon General Anesthetics Market Facts & Figures by Country
  16. 5.5.1 Europe Halogenated Hydrocarbon General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  18. 5.5.3 Europe Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Halogenated Hydrocarbon General Anesthetics Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Halogenated Hydrocarbon General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Halogenated Hydrocarbon General Anesthetics Market Facts & Figures by Country
  41. 5.7.1 South America Halogenated Hydrocarbon General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  43. 5.7.3 South America Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Halogenated Hydrocarbon General Anesthetics Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Halogenated Hydrocarbon General Anesthetics Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Halogenated Hydrocarbon General Anesthetics Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Halogenated Hydrocarbon General Anesthetics Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2021-2032)
  2. 6.1.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Type (2021-2032)
  4. 6.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Type (2021-2032)
  5. 6.2.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Halogenated Hydrocarbon General Anesthetics Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2021-2032)
  2. 7.1.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Halogenated Hydrocarbon General Anesthetics Sales Market Share by Application (2021-2032)
  4. 7.2 Global Halogenated Hydrocarbon General Anesthetics Revenue by Application (2021-2032)
  5. 7.2.1 Global Halogenated Hydrocarbon General Anesthetics Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Halogenated Hydrocarbon General Anesthetics Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Halogenated Hydrocarbon General Anesthetics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Halogenated Hydrocarbon General Anesthetics Value Chain Analysis
  2. 8.1.1 Halogenated Hydrocarbon General Anesthetics Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Halogenated Hydrocarbon General Anesthetics Production Mode & Process
  5. 8.2 Halogenated Hydrocarbon General Anesthetics Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Halogenated Hydrocarbon General Anesthetics Distributors
  8. 8.2.3 Halogenated Hydrocarbon General Anesthetics Customers
9 Global Halogenated Hydrocarbon General Anesthetics Analyzing Market Dynamics
  1. 9.1 Halogenated Hydrocarbon General Anesthetics Industry Trends
  2. 9.2 Halogenated Hydrocarbon General Anesthetics Industry Drivers
  3. 9.3 Halogenated Hydrocarbon General Anesthetics Industry Opportunities and Challenges
  4. 9.4 Halogenated Hydrocarbon General Anesthetics Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst